Loading view.
All Day
Seminar: “Assessing the response and adaptation of the breast cancer kinome to targeted kinase inhibition”
G100 BondurantGary Johnson, PhD, UNC-CH, Pharmacology
Seminar: “Genomic Instability: DNA Damage Response and Cancers: Function and Therapeutic Implications of the ATR Checkpoint Pathway”
00-002 Joseph S. Pagano Conference Room, UNC LinebergerRemi Buisson, PhD, research fellow, MGH Cancer Center, Harvard Medical School